Biochips
are a collection of microarrays or micro-test sites fixed on a solid
substrate to perform multiple tests at the same time for achieving
enhanced speed and throughput. They are small, wafer-like components
that are made from substrates such as soda glass, fused quartz,
silicon, and plastic. Biochips are effectively a miniature laboratory
that functions to perform several biochemical reactions
simultaneously.
INFORMATION
OF BIOCHIPS MARKET WORLDWIDE:
The
positive growth rate in the global biochips market will be due to the
rising investments in biochips technology along with their enhanced
diagnostics applications. Furthermore, greater automation with the
help of biochips is also likely to propel the overall market in the
coming years.
The
global biochips market is segmented on the basis of type,
application, and geography. On the basis of type, this market is
segmented into DNA chips, protein chips, and microfluidic devices.
The applications of biochips are seen in genomics, drug discovery and
development, proteomics, and in vitro diagnostics. Geographically,
this market is segmented into North America, Europe, Asia Pacific,
and Rest of the World.
Among
the various types of biochips, the DNA chips accounted for 40% of
market. The key growth driver supporting this growth is the rising
application of biochips in gene expression profiling, drug discovery,
toxicological research, DNA sequencing, alternative splicing
detection, and diagnostics and genetic engineering.
Amongst
the applications, the drug discovery and development segment emerged
as the leader with a share of 30% in the global biochips market. The
high incidences of various health issues and the need for the
development of new medicines and drugs for treatment are the main
undercurrents deciding the flow of this segment in the overall
market.
Geographically,
North America led the overall market with Asia Pacific in tow.
Analysts predict that Asia Pacific is expected to offer several
growth opportunities to the biochips market in the coming years along
with Rest of the World. Demand from emerging economies of South
Africa, Brazil, UAE, Japan, China, and Australia are expected to
drive this market in the aforementioned regions.
BIOCHIPS
AND ITS TECHNICAL AND PROFESSIONAL ASPECTS:
The
key operators in the global biochips market are Affymetrix Inc.,
Fluidigm Corporation, Illumina Inc., Cepheid Inc., Agilent
Technologies Inc., and GE Healthcare Ltd. amongst others. The
research report profiles these players and provides a complete
analysis of the competitive landscape of the global biochips market.
The report also includes an explanation of the investment
infrastructure, research and development strategies, feasibility of
new projects, business and marketing strategies, and expansion plans
of these top players in the global biochips market.
The
biochips market has been segmented as:
Global
Biochips Market: By Type
>
DNA Chips
>
Protein Chips
>
Microfluidic Devices
Global
Biochips Market: By Application
>
Drug Discovery & Development
>
Genomics
>
Proteomics
>
In Vitro Diagnostics
No comments:
Post a Comment